IiSGM

L1: Searching for new therapeutic alternatives in acute renal failure of different aetiology (nephrotoxic, sepsis, rhabdomyolysis…).

L2: Inhibition of cholesterol rafts as a therapeutic target in ARF

L3: Nephroprotective role of cilastatin in patients subjected to HIPEC-cisplatin.

L4: Effect of renal inflammasome on distant organ damage

L5: Inhibition of cholesterol rafts as a therapeutic target in lung and intestinal damage

L6:      Malaria and acute renal failure

L7: Cardiorenal syndrome, cardiovascular damage in renal failure

Axis 2: CKD progression

L1: Role of colchicine in CKD progression

L2: RAAS blockers in elderly CKD patients without albuminuria

L3: CKD aetiology and progression

L4: Chronic kidney disease prevention and risk stratification

Axis 3: Haemodialysis and complications

L1: Clearance of protein-bound uremic toxins of medium molecular weight: HFR

L2: Potassium levels, dialysate and cardiac arrhythmias

L3: Evaluation of convective transport and online HF techniques on efficacy, tolerability and long-term prognosis of ESRD patients.

Axis 4: Vascular access

L1: Impact of isometric physical exercise in radiocephalic AVFs

Axis 5: Peritoneal dialysis and home haemodialysis

L1: Implementation of new modalities of home dialysis

L2: Efficacy of peritoneal dialysis in refractory heart failure patients

Axis 6: Covid-19

L1: Short- and long-term efficacy of vaccination against SARS-COV2 in patients with CKD, dialysis and renal transplantation: SENCOVAC study.

Axis 7: Acute renal failure

L1: Acute renal failure code in hospitalisation

L2: Protective role of rasburicase in acute renal failure after heart surgery

L3: Acute renal failure in hypertensive disorders of pregnancy

L4: Mortality and prognosis of patients presenting with acute renal failure in hospitalisation

Axis 8: Glomerular Pathology              

L1: FSGMAC-02: Identification of mutations in the MAFB gene in patients with podocytophaties. Analysis of the effect of these mutations in functional and transcriptional polarization human macrophages.

L2: TUBULO01 – Markers of tubular damage in protein nephropathies, historical correlation and progression of chronic renal disease.

Axis 9: ERC Genetics

L1: GENSEN study: Identification of genetic mutations in patients with CKD of non-inherited aetiology